These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19363132)

  • 41. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts.
    Chen Z; Li T; Zhang B
    J Surg Res; 2008 Apr; 145(2):287-94. PubMed ID: 18155248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear-encoded mitochondrial proteins and their role in cardioprotection.
    Boengler K; Heusch G; Schulz R
    Biochim Biophys Acta; 2011 Jul; 1813(7):1286-94. PubMed ID: 21255616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Troxerutin Preconditioning and Ischemic Postconditioning Modulate Inflammatory Response after Myocardial Ischemia/Reperfusion Injury in Rat Model.
    Badalzadeh R; Baradaran B; Alihemmati A; Yousefi B; Abbaszadeh A
    Inflammation; 2017 Feb; 40(1):136-143. PubMed ID: 27807687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial postconditioning: next step to cardioprotection.
    Rohilla A; Rohilla S; Kushnoor A
    Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion.
    Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM
    J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection.
    Randhawa PK; Jaggi AS
    Eur J Pharmacol; 2015 Jan; 746():180-5. PubMed ID: 25449039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of cardioprotection with ageing.
    Boengler K; Schulz R; Heusch G
    Cardiovasc Res; 2009 Jul; 83(2):247-61. PubMed ID: 19176601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preconditioning: can nature's shield be raised against surgical ischemic-reperfusion injury?
    Perrault LP; Menasché P
    Ann Thorac Surg; 1999 Nov; 68(5):1988-94. PubMed ID: 10585117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardioprotection: a radical view Free radicals in pre and postconditioning.
    Penna C; Mancardi D; Rastaldo R; Pagliaro P
    Biochim Biophys Acta; 2009 Jul; 1787(7):781-93. PubMed ID: 19248760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.
    Xiong J; Liao X; Xue FS; Yuan YJ; Wang Q; Liu JH
    Chin Med J (Engl); 2011 Jul; 124(14):2209-15. PubMed ID: 21933628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardioprotection by remote ischemic conditioning and its signal transduction.
    Kleinbongard P; Skyschally A; Heusch G
    Pflugers Arch; 2017 Feb; 469(2):159-181. PubMed ID: 27928644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of Na
    Kingma JG
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):254-269. PubMed ID: 29562750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ubiquitous role of nitric oxide in cardioprotection.
    Jones SP; Bolli R
    J Mol Cell Cardiol; 2006 Jan; 40(1):16-23. PubMed ID: 16288777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pleiotropic preconditioning-like cardioprotective effects of hypolipidemic drugs in acute ischemia-reperfusion in normal and hypertensive rats.
    Ravingerová T; Ledvényiová-Farkašová V; Ferko M; Barteková M; Bernátová I; Pecháňová O; Adameová A; Kolář F; Lazou A
    Can J Physiol Pharmacol; 2015 Jul; 93(7):495-503. PubMed ID: 25965412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction to proceedings of the NHLBI workshop: New Horizons in cardioprotection--a focused issue of journal of cardiovascular pharmacology and therapeutics.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):222. PubMed ID: 21821519
    [No Abstract]   [Full Text] [Related]  

  • 59. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanisms.
    Sharma R; Randhawa PK; Singh N; Jaggi AS
    Eur J Pharmacol; 2015 Dec; 768():58-70. PubMed ID: 26499976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.